Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Fluoroquinolone Resistance Prevalence Study
- Status
- TERMINATED
- Phase
- N/A
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
- Status
- RECRUITING
- Phase
- NA
Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Optical Genome Mapping in Characterization of Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE2
ASH Research Collaborative Data Hub
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
CAR- PRISM (PRecision Intervention Smoldering Myeloma)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
The Ambient Light Multiple Myeloma Study
- Status
- RECRUITING
- Phase
- NA
Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE4